Medicare negotiation

Politics By Rachel Cohrs

The four senators who could make or break Democrats’ drug pricing ambitions

Politics By Nicholas Florko

Underpinning Sinema’s outspoken opposition to major drug pricing reforms: her close ties to Arizona biotechs

Exclusive By Rachel Cohrs and Nicholas Florko

Key Senate committee considers a carveout for small biotech companies in drug pricing reforms

D.C. Diagnosis By Nicholas Florko

What does the Build Back Better Act actually mean for the health care industry?

Exclusive By Rachel Cohrs

How Nancy Pelosi almost killed drug pricing reform — a gamble that expanded Democrats’ final deal

Politics By Rachel Cohrs

Here’s who wins and loses in Democrats’ new prescription drug pricing deal

Politics By Lev Facher and Rachel Cohrs

Democrats circulate a new drug pricing outline with a big carveout for small biotechs

Politics By Nicholas Florko and Rachel Cohrs

Here’s where Democrats’ resurrected drug pricing talks are headed